BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to BioXcel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

BioXcel Therapeutics (BTAI) Reports Q4 Loss of $0.87/sh

March 11, 2021 7:18 AM EST

BioXcel Therapeutics (NASDAQ: BTAI) reported Q4 EPS of ($0.87), versus ($0.45) reported last year.

For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.

... More